This site is intended for health professionals only

Published on 20 February 2009

Share this story:

Profits boost drug firm’s shares


Watson Pharmaceuticals’ announcement that it expects to see a profit and revenue boost this year has prompted a 5.7% rise in its share price.

Shares rose $1.65 (£1.16) to $30.56 in early trading after fluctuating between $20.17 and $32.70 over the last year on the back of growth in its generic drug business.

The company has said expects profits of between $2.18 and $2.28 per share on revenue of $2.65 billion. Last year, the company earned $2.03 per share on revenues of $2.54 billion.

The company said it expects generic drugs to generate the most revenue – between $1.45 billion and $1.55 billion – while branded drugs are expected to contribute $445 million to $470 million.

Revenue at the distribution segment is expected to range between $660 million and $710 million. Analysts expect profit of $2.10 per share on revenue of $2.64 billion.

Copyright Press Association 2009

Watson Pharmaceuticals

Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story: